Design Therapeutics Statistics
NASDAQ: DSGNHealthcareBiotechnologyUSD
11.69-0.28 (-2.34%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Design Therapeutics by the numbers
Design Therapeutics has a market capitalization of $731.6 million based on 62.58M shares outstanding. With trailing EPS of $-1.15, Design Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.3% below its 50-day average and 3.0% below its 200-day average.
Average daily trading volume is 607.69K shares, or about $7.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DSGN valuation vs. peer median
| Metric | DSGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $731.58M | $747.49M | -2% |
| Avg. volume | 607.69K | 1.01M | -40% |
Peer median across 8 companies: SLDB, AVTX, ACHV, GYRE, VSTM, ATTO, APMD, CADL.
Valuation
- Market cap
- $731.58M
- EPS (TTM)
- $-1.15
- Shares outstanding
- 62.58M
Price and trading
- Previous close
- 11.97
- Open
- 11.82
- Day range
- 11.58 – 12.06
- 52-week range
- 5.28 – 17.25
- 52-week change
- +80.12%
- Beta
- —
- Volume
- 344.45K
- Average volume
- 607.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 731.58M
- Forward Pe
- -7.22
- Eps
- -1.15
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.25
- Week52 Low
- 5.28
- Avg Volume
- 607.69K
- Shares Outstanding
- 62.58M
- Ma50
- 13.81
- Ma200
- 12.05
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -32.23%
- Pct From52w Low
- 121.40%